Evidence map›Paper›PMID 34722305›Full record

ReviewFrontiers in oncology2021

A Forgotten Corner in Cancer Immunotherapy: The Role of Lipids.

Yang Yu, Lei Gao, Yunpeng Wang, Bo Xu, Ewetse Paul Maswikiti, Haiyuan Li, Peng Zheng, Pengxian Tao, Lin Xiang, Baohong Gu and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Potential Therapeutic Properties of the Leaf ofPlants (Basel, Switzerland) · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Yang YuDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Lei GaoDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Yunpeng WangDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Bo XuDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Ewetse Paul MaswikitiDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Haiyuan LiDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Peng ZhengDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Pengxian TaoDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Lin XiangDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Baohong GuDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Alexandra LucasCenter for Personalized Diagnostics and Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.
Hao ChenDepartment of Surgical Oncology, Lanzhou University Second Hospital, Lanzhou, China.
Lanzhou University Second Hospital · CNLanzhou University · CNArizona State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade, cancer immunotherapy has achieved great success owing to the unravelling of unknown molecular forces in cancer immunity. However, it is critical that we address the limitations of current immunotherapy, including immune-related adverse events and drug resistance, and further enhance current immunotherapy. Lipids are reported to play important roles in modulating immune responses in cancer. Cancer cells use lipids to support their aggressive behaviour and allow immune evasion. Metabolic reprogramming of cancer cells destroys the equilibrium between lipid anabolism and catabolism, resulting in lipid accumulation within the tumour microenvironment (TME). Consequently, ubiquitous lipids, mainly fatty acids, within the TME can impact the function and phenotype of infiltrating immune cells. Determining the complex roles of lipids and their interactions with the TME will provide new insight for improving anti-tumour immune responses by targeting lipids. Herein, we present a review of recent literature that has demonstrated how lipid metabolism reprogramming occurs in cancer cells and influences cancer immunity. We also summarise the potential for lipid-based clinical translation to modify immune treatment.

Indexed as

fatty acidsimmune evasionimmunotherapylipidstumour microenvironment

Identifiers

PMID34722305
PMCPMC8551635
OpenAlexW3206146363

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.